The contribution of benzene to smoking-induced leukemia

Jeffrey E. Korte, Irva Hertz-Picciotto, Mark R. Schulz, Louise M. Ball, Eric J. Duell

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induced total leukemia deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced AML deaths (95% UCL, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions-all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions.

Original languageEnglish (US)
Pages (from-to)333-339
Number of pages7
JournalEnvironmental Health Perspectives
Volume108
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Benzene
smoking
benzene
Leukemia
Smoking
Tobacco Products
Acute Myeloid Leukemia
Smoke
smoke
Linear Models
Life Tables
life table
Extrapolation
leukaemia
mortality
Mortality
Risk assessment
risk assessment
Health
fold

Keywords

  • Benzene
  • Environmental exposure
  • Epidemiology
  • Leukemia
  • Life tables
  • Occupational exposure
  • Risk assessment
  • Smoking

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Korte, J. E., Hertz-Picciotto, I., Schulz, M. R., Ball, L. M., & Duell, E. J. (2000). The contribution of benzene to smoking-induced leukemia. Environmental Health Perspectives, 108(4), 333-339.

The contribution of benzene to smoking-induced leukemia. / Korte, Jeffrey E.; Hertz-Picciotto, Irva; Schulz, Mark R.; Ball, Louise M.; Duell, Eric J.

In: Environmental Health Perspectives, Vol. 108, No. 4, 2000, p. 333-339.

Research output: Contribution to journalArticle

Korte, JE, Hertz-Picciotto, I, Schulz, MR, Ball, LM & Duell, EJ 2000, 'The contribution of benzene to smoking-induced leukemia', Environmental Health Perspectives, vol. 108, no. 4, pp. 333-339.
Korte, Jeffrey E. ; Hertz-Picciotto, Irva ; Schulz, Mark R. ; Ball, Louise M. ; Duell, Eric J. / The contribution of benzene to smoking-induced leukemia. In: Environmental Health Perspectives. 2000 ; Vol. 108, No. 4. pp. 333-339.
@article{f1947ba2c187415081168abd1de9a6a8,
title = "The contribution of benzene to smoking-induced leukemia",
abstract = "Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48{\%} of smoking-induced total leukemia deaths [95{\%} upper confidence limit (UCL), 20-66{\%}], and from 12 to 58{\%} of smoking-induced AML deaths (95{\%} UCL, 19-121{\%}). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions-all < 1{\%}. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions.",
keywords = "Benzene, Environmental exposure, Epidemiology, Leukemia, Life tables, Occupational exposure, Risk assessment, Smoking",
author = "Korte, {Jeffrey E.} and Irva Hertz-Picciotto and Schulz, {Mark R.} and Ball, {Louise M.} and Duell, {Eric J.}",
year = "2000",
language = "English (US)",
volume = "108",
pages = "333--339",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "4",

}

TY - JOUR

T1 - The contribution of benzene to smoking-induced leukemia

AU - Korte, Jeffrey E.

AU - Hertz-Picciotto, Irva

AU - Schulz, Mark R.

AU - Ball, Louise M.

AU - Duell, Eric J.

PY - 2000

Y1 - 2000

N2 - Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induced total leukemia deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced AML deaths (95% UCL, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions-all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions.

AB - Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induced total leukemia deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced AML deaths (95% UCL, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions-all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions.

KW - Benzene

KW - Environmental exposure

KW - Epidemiology

KW - Leukemia

KW - Life tables

KW - Occupational exposure

KW - Risk assessment

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0034018388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034018388&partnerID=8YFLogxK

M3 - Article

VL - 108

SP - 333

EP - 339

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 4

ER -